Receptor de IL
Los receptores de interleucina (receptores IL) son un grupo de receptores que se unen a las interleucinas, una familia de citocinas que desempeñan roles esenciales en la regulación del sistema inmunológico, la inflamación y la hematopoyesis. La desregulación de la señalización de interleucinas está asociada con diversas enfermedades inflamatorias y autoinmunes, lo que convierte a los receptores IL en objetivos críticos para la intervención terapéutica. Se están explorando los antagonistas de los receptores IL para el tratamiento de afecciones como la artritis reumatoide, la psoriasis y las enfermedades inflamatorias intestinales. En CymitQuimica, ofrecemos una gama de moduladores de receptores IL de alta calidad para apoyar su investigación en señalización de citocinas, inmunología y terapia de enfermedades inflamatorias.
Se han encontrado 112 productos de "Receptor de IL"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
2-Benzothiazolamine
CAS:<p>2-ABT: nitrogen-rich heterocycle used in drug synthesis, inhibits P450, with anti-inflammatory, anticonvulsant, anticancer properties.</p>Fórmula:C7H6N2SPureza:99.09% - 99.3%Forma y color:Plates From Water Physical Description Odorless Gray To White Powder (Ntp 1992)Peso molecular:150.2Levilimab
CAS:<p>Levilimab (BCD-089) is a fully humanized human monoclonal antibody targeting membrane-bound and soluble IL-6 R for the study of rheumatoid arthritis.</p>Pureza:97.8% (SDS-PAGE); 97.3% (SEC-HPLC) - 97.8% (SDS-PAGE); 97.3% (SEC-HPLC)Forma y color:LiquidEnokizumab
CAS:<p>Enokizumab (MEDI-528) is a monoclonal antibody against interleukin IL-9. Enokizumab can be used to study asthma.</p>Pureza:SDS-PAGE:95% SEC-HPLC:99.23%Forma y color:LiquidPeso molecular:145.98 kDaIL-15-IN-1
CAS:<p>IL-15-IN-1 is a selective and potent Interleukin 15 (IL-15) inhibitor, inhibiting the proliferation of IL-15-dependent cells (IC50: 0.8 μM).</p>Fórmula:C30H36N6O4SPureza:99.16%Forma y color:SolidPeso molecular:576.71Ordesekimab
CAS:<p>Ordesekimab (AMG 714) is a human anti-IL-15 IgG1 κ monoclonal antibody for studying NRCD.</p>Pureza:> 95%Forma y color:LiquidPeso molecular:145.12 kDaTildrakizumab
CAS:<p>Tildrakizumab (SCH 900222) is a humanized antibody against IL-23, with a 136 pM Kd, used for psoriasis research.</p>Pureza:> 95%Forma y color:LiquidPeso molecular:144.44 kDaRisankizumab
CAS:<p>Risankizumab (BI 655066) is a monoclonal antibody for psoriasis, targeting IL-23, with high affinity (Kd <10 pM) and an IC50 of 2 pM.</p>Pureza:SDS-PAGE:95.3%;SEC-HPLC:98.3%Forma y color:LiquidPeso molecular:145.85 kDaBriakinumab
CAS:<p>Briakinumab (ABT-874) is a monoclonal antibody targeting IL-12, used in the research of psoriasis multiple sclerosis.</p>Pureza:>95%Forma y color:LiquidSpesolimab
CAS:<p>Spesolimab (BI 655130) is an antibody targeting IL-36 receptor, key in immunity, for systemic pustular psoriasis and dermatitis studies.</p>Pureza:> 95%Forma y color:LiquidPeso molecular:150 kDaNidanilimab
CAS:<p>Nidanilimab (CAN04) is an IL1RAP antibody with 1.10 pM affinity and antitumor effects on NSCLC and PDAC.</p>Pureza:> 95%Forma y color:SoildPeso molecular:150 kDaCanakinumab
CAS:<p>Canakinumab: Human IL-1β antibody, anti-inflammatory, treats gout & coronary disease, IC50 of 43.6 pM (human), 40.8 pM (monkey).</p>Pureza:98.8%Forma y color:LiquidPeso molecular:145.18 kDaPascolizumab
CAS:<p>Pascolizumab (SB-240683) is a humanized monoclonal antibody against IL-4. Pascolizumab has asthmatic effects and can be used to study allergic rhinitis.</p>Pureza:> 95%Forma y color:LiquidPeso molecular:147.18 kDaReslizumab
CAS:<p>Reslizumab (Sch 55700) is a humanized immunoglobulin G (IgG) 4 κ monoclonal antibody, thereby reducing eosinophil production and survival.</p>Pureza:98.1% (SDS-PAGE); 98.6% (SEC-HPLC) - 98.1% (SDS-PAGE); 98.6% (SEC-HPLC)Forma y color:LiquidPeso molecular:N/ADaclizumab
CAS:<p>Daclizumab (Zenapax), a humanized antibody, blocks IL-2 by targeting CD25, used in multiple sclerosis.</p>Pureza:SDS-PAGE:95% SEC-HPLC:99.99%Forma y color:LiquidPeso molecular:144.12 kDaDectrekumab
CAS:<p>Dectrekumab (QAX576) is a humanized monoclonal antibody targeting IL-13.</p>Pureza:96.5% (SDS-PAGE); 97.1% (SEC-HPLC) - 96.5% (SDS-PAGE); 97.1% (SEC-HPLC)Forma y color:LiquidPF-06342674
<p>PF-06342674 is a humanized monoclonal antibody targeting the IL-7 receptor-α, with immunoregulatory activity, used in Type 1 diabetes research.</p>Forma y color:LiquidPeso molecular:145.5kDaTorudokimab
<p>Torudokimab (ZB-880) is a monoclonal antibody that neutralizes interleukin 33 and can be used to study immune system diseases.</p>Pureza:95.8% (SDS-PAGE); 96.2% (SEC-HPLC) - 95.8% (SDS-PAGE); 96.2% (SEC-HPLC)Forma y color:Odour LiquidMepolizumab
CAS:<p>Mepolizumab (SB 240563) is a humanized monoclonal antibody neutralizing IL-5.</p>Pureza:98% - 98%Forma y color:LiquidGuselkumab
CAS:<p>Guselkumab (CNTO 1959) is a recombinant human IgG1 monoclonal antibody targeting the IL-23p19 subunit.</p>Pureza:SDS-PAGE:95% SEC-HPLC:98.97%Forma y color:LiquidPeso molecular:144.8 kDaAnti-inflammatory agent 42
CAS:<p>Anti-inflammatory agent 42 has anti-inflammatory activity and inhibits the expression of TNF-α and IL-6 in LPS-stimulated macrophages.</p>Fórmula:C20H12N2OSPureza:98.13%Forma y color:SolidPeso molecular:328.39
